ARTICLE | Company News
Eli Lilly, Cerecor deal
October 10, 2016 7:00 AM UTC
Eli Lilly granted Cerecor exclusive, worldwide rights to develop and commercialize CERC-611 (formerly LY3130418). Cerecor expects to begin Phase I testing of the transmembrane AMPAR regulatory protei...